Nov 30, 2025 09:05
BMY - Bristol-Myers Squibb Co.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 46.04 0.16 (0.35%) | -0.03 (-0.07%) | -0.05 (-0.1%) | -0.12 (-0.25%) | 0.02 (0.04%) | 0.03 (0.07%) | 0.02 (0.04%) | 0.09 (0.2%) |
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- 0.64
- Diluted EPS:
- 0.64
- Basic P/E:
- 72.1927
- Diluted P/E:
- 72.1927
- RSI(14) 1m:
- 56.03
- VWAP:
- 46.21
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 29, 2025 11:18
Nov 28, 2025 03:50
Nov 24, 2025 18:14
Nov 19, 2025 15:58
Nov 14, 2025 16:17
Nov 14, 2025 10:37
Nov 13, 2025 16:10
Nov 13, 2025 13:00
Nov 07, 2025 12:00